NCT00046917View on ClinicalTrials.gov

Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

March 31, 2010

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

alvocidib

Given IV

DRUG

irinotecan hydrochloride

Given IV

DRUG

cisplatin

Given IV

Trial Locations (1)

10065

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00046917 - Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter